Researchers at Uppsala University and KTH Royal Institute of Technology have developed a new form of precision medicine, an antibody, with the potential to treat several types of cancer. Researchers ...
We often hold it to be self-evident that antibodies are key to an effective immune response against a pathogen—the more (or more potent) antibodies your body makes, the better it will fight off an ...
Scientists compared the blood of nearly 300 individuals with type 1 diabetes to healthy controls, they found that a higher level of antibodies against gentamicin was associated with increased risk of ...
Scientists have stated that the levels of neutralizing antibodies are strongly correlated with the prevention of symptomatic and severe coronavirus disease 2019 (COVID-19), caused by severe acute ...
We are now in the third year of the Covid-19 pandemic. It is likely that Covid and the virus that causes it will be with us for many years. Most of us already have a complex history with Covid-19, ...
COLUMBUS, Ohio — There is some promising news in the fight against COVID-19. Two new types of treatment have arrived at our hospitals in central Ohio. Dr. Joe Gastaldo, of OhioHealth, said the two ...
A cancer-targeting antibody that helps the body's immune cells spot and destroy hard-to-treat tumors such as triple-negative breast cancer has been developed by researchers. The University of ...
Clear vials of medicine with blue caps Researchers say they have identified adverse events that are more likely to occur in cancer patients receiving antibody-drug conjugates. Treatment with ...
Malaria, a pathogen transmitted into blood by mosquitoes in tropical climates, is typically thought of as a blood and liver infection. However researchers have detected antibodies primarily made in ...
Teplizumab has shown significant preservation of C-peptide levels in newly diagnosed type 1 diabetes (T1D) patients, indicating the potential for modifying disease progression. Combining teplizumab ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results